| Financial Year |
March 31 2023 |
| Monetary Funds |
517,500,864.83 |
| Held-for-trading Financial Assets |
80,000,000.00 |
| Notes Receivable |
1,760,000.00 |
| Accounts Receivable |
984,277,546.66 |
| Advances to Suppliers |
6,611,043.39 |
| Other Receivables |
8,970,784.38 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
21,278,830.67 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
12,142,846.16 |
| Other Current Assets |
64,162,741.96 |
| Total Current Assets |
2,104,331,339.83 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
162,446,332.62 |
| Long-term Equity Investment |
137,143,775.39 |
| Investment Properties |
-- |
| Fixed Assetes |
1,297,677,621.39 |
| Under-construction Projects |
51,965,022.18 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,959,574,202.99 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
21,512,210.84 |
| Deferred Income Tax Assets |
32,851,506.47 |
| Other Non-Current Assets |
87,970,449.08 |
| Sub-Total of Non-Current Assets |
3,756,269,465.45 |
| Total Assets |
5,860,600,805.28 |
| Short-Term Loans |
633,034,339.93 |
| Trading Financial liabilities |
-- |
| Notes Payable |
3,277,143.52 |
| Accounts Payable |
571,618,668.50 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
14,395,748.95 |
| Taxes Payable |
35,874,320.45 |
| Interest Payable |
1,558,113.92 |
| Dividend Payable |
-- |
| Other payables |
38,126,346.65 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
136,837,000.41 |
| Other Current Liabilities |
104,262,721.23 |
| Sub-Total of Current Liabilities |
1,541,563,977.66 |
| Long-term Loans |
713,236,104.72 |
| Bonds Payable |
449,116,003.54 |
| Long-Term Accounts Payable |
52,353,432.74 |
| Special Payable |
-- |
| Estimatied Liabilities |
57,959,020.20 |
| Deferred Income Tax Liabilities |
2,184,932.67 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,487,986,443.43 |
| Total Liabilities |
3,029,550,421.09 |
| Paid-In Capital(Or Share Stock) |
534,347,631.00 |
| Capital Surplus |
1,045,436,229.81 |
| Surplus Reserve |
102,445,440.85 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
840,198,577.46 |
| Minority Stockholder's Interest |
232,680,266.65 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,598,370,117.54 |
| Owner's Equity（Stockholder's Equity） |
2,831,050,384.19 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,860,600,805.28 |
